Current and emerging therapies for the management of chronic inflammation in asthma

DeKorte, Carrie J.

doi:10.1093/ajhp/60.19.1949

Cited by 10 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The 4 Hawaii CARES program sites included (1) Kapiolani Medical Center for Women and Children (KMCWC), a university-based, tertiary care children's and women's medical center in urban Honolulu, (2) Kaiser Permanente Medical Center, a general hospital in a residential community of Honolulu serving Kaiser plan patients, (3) Castle Medical Center, a general hospital in a rural/ residential community of northern Oahu, and (4) Waianae Coast Comprehensive Health Center, a large clinic in a rural community in western Oahu with a 24-hour emergency care center. Pali Momi Medical Center, a general hospital in a residential Oahu community, participated briefly, contributing 5 patients before declining additional participation.…”

Section: Participating Ed Centersmentioning

confidence: 99%

“…1,2 Accordingly, children and their families need to be a key focus for self-management education. 3 National Asthma Education and Prevention Program (NAEPP) guidelines provide a blueprint for such education. 1 To evaluate the status of childhood asthma and its care, assess health care provider adherence to guidelines, and create an integrated system of asthma care, the Hawaii Child Asthma Research to Elevate Standards (CARES) program was developed.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Change in Approach and Delivery of Medical Care in Children With Asthma: Results From a Multicenter Emergency Department Educational Asthma Management Program

et al. 2006

View full text Add to dashboard Cite

OBJECTIVES. The Hawaii Child Asthma Research to Elevate Standards (CARES) Program implemented an emergency department (ED)-based education and management program to facilitate National Asthma Education and Prevention Program (NAEPP) guideline understanding among asthmatic children and their families, ED staff, and health care providers.METHODS. The multipronged approach used: (1) 2-phased prospective tracking system of ED asthma patients; (2) ED-based educational intervention for patients/ families; and (3) asthma education for ED staff and community-based health care providers. Data were collected across 4 EDs during phase I (October 8, 2002, to October 1, 2003 and phase II (October 1, 2003, to July 8, 2004. Follow-up data were collected by telephone 3 weeks (phase I), and 3 weeks and 3 months (phase II) after the ED encounter. The patient/family intervention was delivered throughout phase II. During phase I, ED and community-based health care professionals developed strategies for building an integrated asthma care system. ED staff training was delivered before phase II. Continuing medical education for health care providers was delivered before and during the first month of phase II.RESULTS. Tracking data on 706 phase I and 353 phase II patient encounters revealed that the majority of patients with persistent asthma did not use long-term controller medications and did not possess a written asthma action plan. From preintervention to postintervention, the number of patients possessing a written asthma action plan increased from 48 to 322. Of 186 persistent asthmatics, 34 were using controller medications daily, 34 as needed, and 118 not at all. Daily use increased to 80 3 weeks postintervention and to 68 3 months postintervention. A LTHOUGH THERE IS no cure for asthma, self-management can prevent acute asthma exacerbations and irreversible damage to airway function, and improve patients' quality of life (QoL). 1,2 Accordingly, children and their families need to be a key focus for self-management education. 3 National Asthma Education and Prevention Program (NAEPP) guidelines provide a blueprint for such education. 1 To evaluate the status of childhood asthma and its care, assess health care provider adherence to guidelines, and create an integrated system of asthma care, the Hawaii Child Asthma Research to Elevate Standards (CARES) program was developed. The program was directed from the University Tertiary Care Pediatric Teaching Center at the John A. Burns School of Medicine, Kapi'olani Medical Center for Women and Children. Because the medically underserved areas of northeast and west Oahu coincide with the highest incidence of asthma within Honolulu County, 4 medical institutions serving these communities were invited to develop the program jointly. A multiethnic, culturally sensitive approach to data collection was developed to obtain accurate information from this diverse population to develop and implement an emergency department (ED)-based asthma education program for patients, families, and ...

show abstract

Section: Participating Ed Centersmentioning

confidence: 99%

mentioning

confidence: 99%

Change in Approach and Delivery of Medical Care in Children With Asthma: Results From a Multicenter Emergency Department Educational Asthma Management Program

et al. 2006

View full text Add to dashboard Cite

show abstract

“…The precise role of IGIV must be defined relative to monoclonal antibodies that target various inflammatory-response receptors, leukotriene modifiers, phosphodiesterase-4 inhibitors, cytokine-receptor antagonists, and other new drugs. 42,43…”

Section: Hematologic Disordersmentioning

confidence: 99%

The Patient: Emerging Clinical Applications of Intravenous Immunoglobulin

Harvey¹

2005

Pharmacotherapy

View full text Add to dashboard Cite

Intravenous immunoglobulin (IGIV) originally was used as prophylactic treatment of infections in patients with primary immunodeficiency disease. Today, administration of IGIV, due in large part to its immunomodulatory activity, has expanded to include a number of other disorders. Available data suggest that the accepted indications for IGIV will continue to expand. As the number of clinical applications for this therapy grows, so will market opportunities; current preparations will be modified and improved and new products introduced. Intravenous immunoglobulin therapy has improved the lives of many patients with immune-related disorders. Future applications will ideally advance this paradigm further.

show abstract

Astma

Kerremans¹

2004

MFAM

View full text Add to dashboard Cite

show abstract

Current and emerging therapies for the management of chronic inflammation in asthma

Cited by 10 publications

References 0 publications

Change in Approach and Delivery of Medical Care in Children With Asthma: Results From a Multicenter Emergency Department Educational Asthma Management Program

Change in Approach and Delivery of Medical Care in Children With Asthma: Results From a Multicenter Emergency Department Educational Asthma Management Program

The Patient: Emerging Clinical Applications of Intravenous Immunoglobulin

Astma

Contact Info

Product

Resources

About